“…Myocarditis can have a variety of clinical manifestations such as chest pain, new or worsening heart failure, chronic heart failure, life-threatening hemodynamic compromise (i.e., fulminant myocarditis, with cardiogenic shock and severely reduced LVEF), life-threatening arrhythmias, or conduction disturbances [ 15 ]. Diagnostic tools used when myocarditis is suspected include cardiac MRI, which has the highest sensitivity if performed two to three weeks after the initial clinical presentation, endomyocardial biopsy, which remains the gold-standard technique to diagnose acute myocarditis [ 16 ] and reveals an inflammatory infiltrate with necrosis or degeneration of adjacent myocytes, markers of myocyte injury and inflammation such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) although not specific and not necessarily increased in myocarditis, high sensitivity troponins, brain natriuretic peptide (BNP) and NT-proBNP (useful but not specific) [ 15 ]. Ten months after the initial presentation, the patient presented with new-onset heart failure in the setting of fluid overload with failed peritoneal dialysis two months prior (eight months after the initial presentation).…”